330 related articles for article (PubMed ID: 36562462)
1. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK
Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
3. Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes.
Kanervo M; Tupola S; Nikkola E; Rantakari K; Kahila H
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():106-110. PubMed ID: 38608352
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine exposure to maternal opioid maintenance treatment and associated risk factors may impair child growth.
Kanervo M; Luoto L; Tupola S; Nikkola E; Kahila H; Rantakari K
Acta Paediatr; 2024 Jul; 113(7):1579-1591. PubMed ID: 38456564
[TBL] [Abstract][Full Text] [Related]
5. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis.
Link HM; Jones H; Miller L; Kaltenbach K; Seligman N
Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100179. PubMed ID: 33345863
[TBL] [Abstract][Full Text] [Related]
8. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
9. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Johnson S; Martin PR
Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
[TBL] [Abstract][Full Text] [Related]
10. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
[TBL] [Abstract][Full Text] [Related]
12. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
13. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
Nguyen L; Lander LR; O'Grady KE; Marshalek PJ; Schmidt A; Kelly AK; Jones HE
Am J Addict; 2018 Mar; 27(2):92-96. PubMed ID: 29473258
[TBL] [Abstract][Full Text] [Related]
14. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
Srivastava A; Kahan M; Nader M
Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
[TBL] [Abstract][Full Text] [Related]
15. "Will My Baby Be OK?" A Qualitative Analysis of Pregnant Women's Suboxone
Moore DJ; Butzlaff A
J Am Psychiatr Nurses Assoc; 2023; 29(3):185-193. PubMed ID: 37038973
[TBL] [Abstract][Full Text] [Related]
16. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
18. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Management of Opioid Use Disorder in Pregnant Women.
Wilder CM; Winhusen T
CNS Drugs; 2015 Aug; 29(8):625-36. PubMed ID: 26315948
[TBL] [Abstract][Full Text] [Related]
20. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
